Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-receptor-mediated increase in venous return in humans.

F H Leenen1, R A Reeves

  • 1Hypertension Unit, Toronto Western Hospital, Ont., Canada.

Canadian Journal of Physiology and Pharmacology
|August 1, 1987
PubMed
Summary

Beta-1 and beta-2 receptors in humans both enhance venous return and heart function. Beta-1 receptors are key for sympathetic nervous system responses, influencing heart rate and contractility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The activity of family 11 xylanases at alkaline pH.

New biotechnology·2010
Same author

Alteration of the pH optimum of a family 11 xylanase, XynB6 of Dictyoglomus thermophilum.

New biotechnology·2010
Same author

The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.

Journal of psychopharmacology (Oxford, England)·2008
Same author

Omapatrilat provides long-term control of hypertension: a randomized trial of treatment withdrawal.

Journal of clinical hypertension (Greenwich, Conn.)·2002
Same author

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.

Controlled clinical trials·2001
Same author

Effects of omapatrilat on pharmacodynamic biomarkers of neutral endopeptidase and Angiotensin-converting enzyme activity in humans.

Current hypertension reports·2001

Area of Science:

  • Cardiovascular Physiology
  • Autonomic Nervous System Pharmacology

Background:

  • Beta-adrenergic receptors play a crucial role in cardiovascular regulation.
  • Understanding the specific roles of beta-1 and beta-2 receptors in venous return is essential for comprehending cardiac function.

Purpose of the Study:

  • To investigate the distinct contributions of beta-1 and beta-2 adrenergic receptors to the regulation of venous return in humans.
  • To differentiate receptor involvement during both exogenous catecholamine stimulation and endogenous sympathetic activation.

Main Methods:

  • Assessed changes in left ventricular end-diastolic (LVED) dimension during beta-receptor stimulation.
  • Utilized exogenous catecholamines (isoproterenol, terbutaline, epinephrine) and hydralazine to modulate sympathetic activity.
  • Administered nonselective and beta-1 selective beta-receptor blockade to delineate receptor-specific effects.

Main Results:

  • Both beta-1 and beta-2 receptor stimulation, via catecholamines or hydralazine, increased venous return, heart rate, and myocardial contractility.
  • Nonselective and beta-1 selective blockade similarly attenuated responses to hydralazine.
  • Beta-1 selective blockade partially inhibited epinephrine's effects, while nonselective blockade reversed the increase in venous return.

Conclusions:

  • Stimulation of both beta-1 and beta-2 receptors contributes to increased venous return, heart rate, and contractility in healthy humans.
  • Beta-1 receptors appear to be the primary mediators of increased venous return during neuronal sympathetic activity.

Related Experiment Videos